Recall: D-0821-2026
Class II - Potentially Harmful
Class IIClassification
2026-08-06Initiated
OngoingStatus
Baxter Healthcare CorporationFirm
Product
Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.
Reason
CGMP Deviations
Distribution
US Nationwide; Puerto Rico; and Chile.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.